The wide and rapid spread of the COVID-19 pandemic has placed an unanticipated burden
on the global healthcare sector. This necessitated a swift response from the international …

Pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced
COVID-19 implied the presence of excessive proinflammatory cytokines and chemokines in …

Abstract Background The World Health Organization (WHO) announced the COVID-19
occurrence as a global pandemic in March 2020. The treatment of SARS-CoV-2 patients is …

Several drugs and antibodies have been repurposed to treat COVID-19. Since the outcome
of the drugs and antibodies clinical studies have been mostly inconclusive or with lesser …

The underlying cause of many complications associated with severe COVID-19 is attributed
to the inflammatory cytokine storm that leads to acute respiratory distress syndrome (ARDS) …

Due to a lack of definitive treatment, many drugs were repurposed for Coronavirus disease
(COVID-19) treatment; among them, corticosteroid is one. However, its benefit or harm while …

Abstract Background In March 2020, the World Health Organization declared the
coronavirus disease 2019 as a global pandemic. Though antiviral drugs and antimalarial …

Due to the fact that coronavirus disease 2019 (COVID-19) is still prevalent, and current
reports show that some parts of the world have seen increase in incidence, it is relevant that …

Untitled Page 1 Page 2 糖皮质激素用于治疗 2019 冠状 病毒病(COVID-19) 活的指导 2020 年
9 月 2 日 WHO reference number: WHO/2019-nCoV/Corticosteroids/2020.1 © 世界卫生组织 …

Coronavirus disease 19 (COVID-19) is placing a major burden on healthcare, economy and
social systems worldwide owing to its fast spread and unacceptably high death toll. The …